Partner Don Schroeder was quoted in a Society for Human Resource Management (SHRM) article, “New NLRB Acting Chairman May Tilt Board Pro-Business,” covering President Donald Trump’s naming of Philip Miscimarra as acting chairman of the National Labor Relations Board (NLRB) and the agency’s shift toward business interests.
While the Trump administration’s decision to place Miscimarra at the helm of the NLRB marks a change in the agency’s direction, Schroeder notes that dramatic changes will not be seen until the two vacancies left on the board have been filled. Miscimarra will have a say on current cases on the NLRB’s agenda as acting chair, however, Schroeder predicts that the Trump administration will name its nominees within 60 days.
While the Trump administration’s decision to place Miscimarra at the helm of the NLRB marks a change in the agency’s direction, Schroeder notes that dramatic changes will not be seen until the two vacancies left on the board have been filled. Miscimarra will have a say on current cases on the NLRB’s agenda as acting chair, however, Schroeder predicts that the Trump administration will name its nominees within 60 days.
People
Related News
June 26, 2025
In the News
Alejandro Gomez-Strozzi on Mexico-US Auto Parts Trade – 'Going forward, there is nothing but integration'
Foley & Lardner lLP partner Alejandro Gómez-Strozzi shared insights on foreign direct investment around Mexico's automotive parts sector in the El Economista article, "Efecto Trump pega más a IED en autopartes que en autos y camiones."
June 25, 2025
In the News
Jocelyn Lavallo Explores Nuclear's Emerging Role in Project Finance
Foley & Lardner LLP partner Jocelyn Lavallo examined the increasing relevance of advanced nuclear technologies in the evolving clean energy landscape in her Environment+Energy Leader article, "Nuclear’s Emerging Role in Project Finance: A Cross-Technology Perspective."
June 25, 2025
In the News
Kyle Faget Comments on AI, User Fees Ahead of MDUFA Negotiations
Foley & Lardner LLP partner Kyle Faget weighed in on the role of user fees and artificial intelligence as stakeholders prepare for the next Medical Device User Fee Amendments (MDUFA) reauthorization in the Medtech Insight article, "Will Kennedy And Makary Come To Terms On User Fees During Next Round Of MDUFA Negotiations?"